CD86 and myocardial infarction: The OHA-PL@Exo hydrogel demonstrated the ability to eliminate reactive oxygen species, reduce the expression of the M1 macrophage-related protein CD86, and diminish inflammation during the initial stage of myocardial infarction (MI) [118].